ESC Premium Access

Prognostic implication of sodium nitroprusside vasodilator test in pulmonary hypertension and left heart disease: insights from PUSHON registry.

Congress Presentation

About the speaker

Doctor Paolo Boretto

University of Turin, Turin (Italy)
0 follower

5 more presentations in this session

Combined pre- and post-capillary pulmonary hypertension defined by new criteria is worse prognosis group in patients with heart failure

Speaker: Doctor T. Ibe (Saitama, JP)


Prognostic role of comorbidities in patients with pulmonary arterial hypertension

Speaker: Doctor A. De Lorenzis (Bologna, IT)


Clinical characteristics and prognostic impact of pulmonary hypertension in heart failure with preserved ejection fraction: the PURSUIT HFpEF study

Speaker: Doctor F. Sera (Suita, JP)


The association between atrial fibrillation and pulmonary embolism

Speaker: Doctor E. Svennberg (Stockholm, SE)


Modeling survival using decision tree analysis in pulmonary hypertension due to left heart disease. the prognostic significance of PVR < 3WU when TAPSE < 16mm

Speaker: Mr C. Fauvel (Rouen, FR)


Access the full session

The Conundrum of Pulmonary Hypertension due to Left Heart Disease – Can Science Help?

Speakers: Doctor P. Boretto, Doctor T. Ibe, Doctor A. De Lorenzis, Doctor F. Sera, Doctor E. Svennberg...

About the event


ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk